Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 12/20 | 0.62 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.58 |
| ▸ | SELL | P14151 | 1/20 | 0.55 |
| ▸ | SELP | P16109 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21318889 | 1.00 | MAG (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL8673965 | 1.00 | MAG (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL29358356 | 0.96 | MAG (0.64) | MAGSIGLEC7SELLSELP | |
| SCHEMBL29790139 | 0.95 | SIGLEC7 (0.63) | MAGSIGLEC7SELLSELP | |
| SCHEMBL29809799 | 0.95 | SIGLEC7 (0.63) | MAGSIGLEC7SELLSELP | |
| SCHEMBL29540690 | 0.94 | MAG (0.64) | MAGSIGLEC7SELLSELP | |
| SCHEMBL30206509 | 0.93 | MAG (0.70) | MAGSIGLEC7 | |
| SCHEMBL29395515 | 0.93 | MAG (0.61) | MAGSIGLEC7SELLSELP | |
| SCHEMBL27420908 | 0.93 | MAG (0.64) | MAGSIGLEC7SELLSELP | |
| SCHEMBL23857822 | 0.88 | MAG (0.62) | MAGSIGLEC7SELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220143056-A1 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-05-12 | — | — | US | disclosed |
| US-11234992-B2 | Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-01 | — | — | US | disclosed |
| US-20190269713-A1 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190269713-A1 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | APOB, LDLR, PCSK9 | MAG 655/4885SIGLEC7 83/4885SELL 76/4885 |
| US-11234992-B2 | Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides | APOB, LDLR, PCSK9 | MAG 655/4885SIGLEC7 83/4885SELL 76/4885 |
| US-20220143056-A1 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | APOB, LDLR, PCSK9 | MAG 655/4885SIGLEC7 83/4885SELL 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.